NanoVibronix (NAOV) announced the completion of the acquisition of ENvue Medical Holdings. The company said, “This strategic transaction will ...

GE HealthCare expects 2025 adjusted profit of between $4.61 and $4.75 per share, with the midpoint above analysts' average ...

The USAN designation reflects Okyo Pharma’s commitment to developing new therapies for unmet medical needs in ophthalmology. The suffix “-mod” in urcosimod denotes its classification as a modulator of ...

The Food and Drug Administration this week approved a new type of painkiller that doesn’t carry the risk of addiction or overdose associated with opioid medications. The drug, suzetrigine ...

The new indications, approved Tuesday by the FDA, make Ozempic the most broadly indicated drug in its class, with the largest set of specific medical conditions that it may be prescribed to treat.

visit our medical review board. When you buy through our links, Business Insider may earn an affiliate commission. Learn more Flying with a cat is stressful, but one of the best airline-approved ...

Luton Airport's expansion plans are expected to be approved by the Government after Rachel Reeves said the need for economic growth trumps other concerns. The airport is looking to build a new ...

The decision leaves refugees who have completed a lengthy process stranded abroad and facing extended separation from loved ones already in the U.S. By Miriam Jordan and Hamed Aleaziz Miriam ...

The Senate voted on Monday to confirm Marco Rubio as President Donald Trump’s secretary of state, the first high-level Cabinet official for the new administration to be approved by the chamber.

Esketamine is the first monotherapy for MDD with inadequate response to two oral antidepressants, approved after a priority FDA review. Clinical trials showed esketamine's rapid efficacy ...

Jannik Sinner, the world No 1 and defending champion, looked to be heading out of the Australian Open until he was rescued by a controversial medical timeout. On the hottest day of the tournament ...

Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for Parkinson's disease from cell-to-cell in the brain. In a paper published last ...